Clinical trials: Burn Excisional Surgery
Burn, Trauma Wound
Multicenter Single-arm Trial to Investigate Clinical Outcomes When Cohealyx™ is Used for Full Thickness Wounds
The goal of this study is to look at clinical outcomes when Cohealyx Collagen Matrix is used to treat full thickness wounds after surgical excision in patients that require a skin graft to heal their wounds.
- Conditions
- Burn, Trauma Wound, Full Thickness Wounds, Surgical Wound
- Trial name
- Cohealyx I (NCT06787690)
- Testing
- Cohealyx
- Where
- 18 sites in United States
- Volunteers
- 41 people
- Sponsor
- Avita Medical
Tranexamic Acid, Burn
TXA Study in Major Burn Surgery
Major surgery can result in blood loss that can require a blood transfusion during and/or after surgery. Tranexamic acid (TXA) is a medication that was first introduced in the 1960's as a treatment for heavy menstrual bleeding.
- Conditions
- Tranexamic Acid, Burn, Major Surgery
- Trial name
- NCT02753816
- Testing
- Tranexamic Acid
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- Corewell Health West
Burns, Blood Loss, Surgical
Tranexamic Acid During Excisional Burn Surgery
The purpose of this study is to access the efficacy of the drug tranexamic acid in reducing blood loss during burn excision surgery.
- Conditions
- Burns, Blood Loss, Surgical, Blood Loss, Tranexamic Acid
- Trial name
- TRANEX (NCT05507983)
- Testing
- Tranexamic acid
- Where
- 3 sites in Netherlands
- Volunteers
- 96 people
- Sponsor
- Maasstad Hospital
Tranexamic Acid, Burns
TRANexamic Acid to Reduce Bleeding in BURN Surgery
Excision and grafting in burn patients can lead to severe blood loss. A preliminary study conducted in Saint Joseph Saint Luc Hospital showed that the total median blood loss was 1412 mL (1).
- Conditions
- Tranexamic Acid, Burns, Surgery, Wounds and Injuries
- Trial name
- TRANBURN (NCT03113253)
- Testing
- Tranexamic Acid
- Where
- 4 sites in France
- Volunteers
- 121 people
- Sponsor
- Centre Hospitalier Saint Joseph Saint Luc de Lyon
Burns Surgery
Antibioprophylaxis for Excision-graft Surgery in Burn Patient (A2B-TRIAL)
The indication of antibiotic prophylaxis in burn patients remains highly controversial and hasn't reached a consensus. The objective of antibiotic prophylaxis would be to reduce the risk of post-operative local and systemic…
- Trial name
- A2B (NCT04292054)
- Testing
- active intervention
- Where
- France
- Volunteers
- 506 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Blood Loss, Surgical
Safety and Immunogenicity Study of Recombinant Thrombin (rThrombin) in Pediatric Participants
The objective of this study is to assess the safety and immunogenicity of recombinant thrombin (rThrombin) administered as an aid to hemostasis during burn wound excision and skin grafting in pediatric patients, newborn through…
- Trial name
- NCT00859547
- Testing
- rThrombin, 1000 IU/mL
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- ZymoGenetics